RECENT NEWS

Visit the WFH News page to find out more about the events and developments that are making a difference today.

14th WFH Global Forum: explore the program today, join the conversation in November

14th WFH Global Forum: explore the program today, join the conversation in November

The 14th WFH Global Forum on Advances and Access to Safe Treatment Products for Bleeding Disorders will take place from November 13 to 14, 2025, in Montreal, Canada. The WFH is pleased to announce that the full program is now available!

Also available in: Français Español

The future of treatment is taking shape—be there to help define it! Bringing science, technology, and policy into one conversation, the 14th WFH Global Forum on Advances and Access to Safe Treatment Products for Bleeding Disorders is a unique meeting that fosters open dialogue and collaboration across a range of different stakeholders. You can see all the sessions and speakers here.

This year’s program will explore a wide range of topics, from safety and surveillance to bias and gaps in women’s care, and the evolving treatment landscape for von Willebrand disease (VWD). It will also provide and in-depth look at rebalancing agents, the impact of artificial intelligence on hemophilia care, and access to gene therapy. Overarching themes of policy, procurement, and sustainability will be explored throughout the Forum, as these ultimately determine whether innovation can translate into real-world access for people with bleeding disorders worldwide. The event will conclude with a look at the next round of innovations, highlighting emerging strategies that continue to advance treatment options, supporting the WFH vision of Treatment for All.

Registration is now open! Don’t miss your chance to join this important global conversation: secure your spot in Montreal today by registering here.

The 14th edition of the WFH Global Forum is supported by funding from: CSL Behring, Pfizer, Sanofi, Sobi, with additional support from Biomarin.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.